Page last updated: 2024-08-25

cholest-5-ene-3,4-diol and Heart Failure

cholest-5-ene-3,4-diol has been researched along with Heart Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akutsu, S; Hoshikawa, K; Kawakami, J; Maekawa, Y; Naito, T; Saotome, M	1

Other Studies

1 other study(ies) available for cholest-5-ene-3,4-diol and Heart Failure

Article	Year
Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients. Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:4 Topics: Aged; Aged, 80 and over; Alleles; Antidiuretic Hormone Receptor Antagonists; ATP Binding Cassette Transporter, Subfamily B; Cholesterol; Cytochrome P-450 CYP3A; Female; Genotype; Heart Failure; Humans; Hydroxycholesterols; Male; Sodium; Tolvaptan; Vitamin D	2020

Article

Year

Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients.

Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:4

Topics: Aged; Aged, 80 and over; Alleles; Antidiuretic Hormone Receptor Antagonists; ATP Binding Cassette Transporter, Subfamily B; Cholesterol; Cytochrome P-450 CYP3A; Female; Genotype; Heart Failure; Humans; Hydroxycholesterols; Male; Sodium; Tolvaptan; Vitamin D

2020